Loading...

Home
Stock
CYTK

CYTK News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

CYTK News

Cytokinetics Board Faces Claims of Breach of Fiduciary Duty as Stock Plummets

Jan 22 2026Businesswire

Stocks to Consider Buying in 2026: Insights from Our Roundtable Experts, Including DoorDash and LVMH

Jan 16 2026Barron's

Cytokinetics (CYTK) and FuboTV (FUBO) Options Volume Surge

Jan 12 2026NASDAQ.COM

Cytokinetics Faces Shareholder Investigation Over Alleged Misleading Statements

Jan 02 2026Globenewswire

Biotech Stocks Surge at Year-End 2025, ETFs Gain 35.84%

Dec 31 2025Benzinga

Cytokinetics Faces Shareholder Investigation Over Alleged Misstatements

Dec 30 2025Globenewswire

Edgewise Therapeutics Updates EDG-7500 Phase 2 Trial Progress, Shares Rise 17.96%

Dec 24 2025Benzinga

CYTK Receives FDA Approval for Myqorzo, Launch Expected in 2026

Dec 22 2025Newsfilter

CYTK Events

No data

No data

CYTK Monitor News

Cytokinetics stock rises amid sector rotation despite shareholder investigation

Cytokinetics Receives FDA Approval for MYQORZO, Driving Stock Surge

Cytokinetics faces shareholder investigation amid FDA review delay

CYTK Earnings Analysis

Cytokinetics Earnings Report: Key Highlights & Forecast- Intellectia AI™

Cytokinetics Q4 2024: Earnings Growth & Strategic Milestones- Intellectia AI™

People Also Watch